Process for preparing N-methyl derivatives of ergoline

Information

  • Patent Grant
  • 4754037
  • Patent Number
    4,754,037
  • Date Filed
    Thursday, July 10, 1986
    38 years ago
  • Date Issued
    Tuesday, June 28, 1988
    36 years ago
Abstract
A process for preparing an N-methyl derivative of ergoline of formula: ##STR1## in which R.sub.1 denotes a carboxy or alkoxycarbonyl group in which the alkyl portion contains 1 to 4 carbon atoms, R.sub.2 denotes a hydrogen atom or a methoxy group and R.sub.3 denotes a hydrogen atom or R.sub.2 and R.sub.3 together form a direct bond, or in which R.sub.1 denotes a hydroxymethyl group, R.sub.2 denotes a hydrogen atom or a methoxy group and R.sub.3 denotes a hydrogen atom, which comprises methylating an ergoline derivative of formula: ##STR2## in which R.sub.1, R.sub.2 and R.sub.3 are defined as above, with methyl carbonate in the presence of a basic agent, in an apolar aprotic solvent in the present of a phase transfer catalyst.
Description

The present invention relates to a process for preparing N-methyl derivatives of ergoline.
These compounds are useful intermediates for preparing compounds which have pharmacological activity, such as peripheral and cerebral vasodilators (nicergoline) or migraine prophylactics (methysergide, metergoline).
It is generally known to carry out the methylation of an indole ring-system, with a methyl halide or dimethylsulphate, in the presence of a base which is an alkali metal hydroxide or a hydride, amide or alcoholate or organometallic derivative such as an organomagnesium or organolithium derivative (see M. G. Reinecke, J. Org. Chem., 37 (20) 3066 (1972)). However, this technique does not give satisfactory results when the indole ring-system bears nitrogen-containing or hydroxyl substituents.
French Patent No. 1,359,563 describes the methylation of the nitrogen atom of the ergoline ring system by the action of a methyl halide in liquid ammonia in the presence of metallic potassium.
German Patent Application Nos. 2,618,033 and 3,007,196 described the methylation of an aniline using methyl carbonate at a temperature of from 180.degree. to 250.degree. C. or using methyl carbonate and methyl iodide at a temperature in the region of 150.degree. C.
French Patent Application No. 2,478,639 describes the methylation of one particular indole derivative, 1-(2-(3-indolyl)ethyl)-2-pyrrolidone, using methyl carbonate in the presence of sodium hydride, the mixture being heated for 6 hours to the reflux temperature of tetrahydrofuran. However, the application of this process to the methylation of ergoline derivatives does not leed to satisfactory results.
The present invention provides a process for the preparation of an N-methyl derivative of ergoline of formula: ##STR3## in which R.sub.1 denotes a carboxy or alkoxycarbonyl group in which the alkyl portion contains 1 to 4 carbon atoms, R.sub.2 denotes a hydrogen atom or a methoxy group and R.sub.3 denotes a hydrogen atom or R.sub.2 and R.sub.3 together from a direct bond, or in which R.sub.1 denotes a hydroxymethyl group. R.sub.2 denotes a hydrogen atom or a methoxy group and R.sub.3 denotes a hydrogen atom, which comprises methylating an ergoline derivative of formula: ##STR4## in which R.sub.1, R.sub.2 and R.sub.3 are defined as above, with methyl carbonate in the presence of a basic agent such as an alkali metal hydride or alcoholate, for example sodium or potassium hydride or alcoholate, in an apolar aprotic solvent in the presence of a phase transfer catalyst, such as a quaternary ammonium salt, for example tetrabutylammonium chloride, and optionally in the presence of a sequestering agent such as a crown ether or a compound of formula:
N(CH.sub.2 CH.sub.2 (OCH.sub.2 CH.sub.2).sub.n OCH.sub.3).sub.3
wherein n is 1, 2 or 3.
The reaction is generally carried out at a temperature of from 0.degree. to 100.degree. C., preferably from 40.degree. to 60.degree. C.
Ethers, esters, nitriles or aromatic hydrocarbons are examples of compounds which can be used as apolar aprotic solvents. The process can be carried out in methyl carbonate itself, which therefore acts as both the methylating agent and the solvent and which, as a result of its relatively low boiling point (90.degree. C.), can be readily removed.
The process according to the invention enables the methylation reaction to be carried out under mild conditions, using compounds which can be more readily handled than other methylating agents such as methyl halides and dimethyl sulphate. Methyl carbonate is, in particular, much less toxic.
When the ergoline ring-system is substituted with a tertiary amine or primary alcohol group, the side reactions which occur with the other known methylating agents, such as quaternization of the tertiary amine or etherification of the primary alcohol, do not generally take place. However, if the ergoline ring-system is substituted with a primary alcohol group it can be advantageous to treat the reaction product with a base such as sodium hydroxide before isolating the final product.
When the ergoline ring-system is substituted with an ester group, especially a methyl ester group, the group is prevented from undergoing a saponification reaction due to the conditions in which the process according to the invention is carried out.





The example which follow show how the invention may be put into practice.
EXAMPLE 1
A solution of methyl 10.alpha.-methoxylumilysergate (314 mg; 10.sup.-3 mol) in methyl carbonate (25 cc) was poured into a reactor containing sodium methylate (16.times.10.sup.-3 mol) and tetrabutylammonium chloride (1.75.times.10.sup.-3 mol).
The reaction mixture, maintained shielded from moisture, was stirred for 24 hours at a temperature in the region of 20.degree. C.
Assay of the reaction mixture by high performance liquid chromatography showed that it contained methyl N-methyl-10.alpha.-methoxylumilysergate (0.8.times.10.sup.-3 mol).
The degree of conversion was 97%.
EXAMPLE 2
Tetrabutylammonium chloride (1.5 mmol) and sodium methylate (24 mmol) was added successively to a solution of methyl 10.alpha.-methoxylumilysergate (943 mg; 3 mmol) in methyl carbonate (100 cc).
The reaction mixture, maintained shielded from moisture, was stirred for 3 hours 30 minutes at 60.degree. C. The reaction mixture then contained methyl N-methyl-10.alpha.-methoxylumilysergate (2.83 mmol), which corresponded to a 94% yield.
The degree of conversion of the methyl 10.alpha.-methoxylumilysergate was 98.5%.
Acetic acid (24 mmol) was added to the reaction mixture, which was then filtered on silica. The methyl N-methyl-10.alpha.-methoxylumilysergate, the characteristics of which were confirmed by proton nuclear magnetic resonance and high performance liquid chromatography, was thereby isolated.
EXAMPLE 3
10.alpha.-Methoxylumilysergol (268 mg; 1 mmol) was suspended in a mixture (30 cc) of methyl carbonate and tetrahydrofuran (1:1 by volume). Sodium methylate (8 mmol) and tetrabutylammonium chloride (2 mmol) were then added. The reaction mixture was stirred for 5 hours at 60.degree. C. The solvents were evaporated off under reduced pressure and a methanol/water (4:1 by volume) mixture (30 cc) was then added. The aqueous methanolic solution was heated to 60.degree. C. for 3 hours.
N-Methyl-10.alpha.-methoxylumilysergol was isolated after precipitation by adding water at a temperature in the region of 10.degree. C.
The yield of N-methyl-10.alpha.-methoxylumilysergol was 96%.
The degree of conversion of the 10.alpha.-methoxylumilysergol was 98%.
The structure of the product obtained was confirmed by nuclear magnetic resonance and high performance liquid chromatography.
EXAMPLE 4
The procedure of Example 2 was repeated, but using:
methyl 10.alpha.methoxylumilysergate: 1 mmol methyl carbonate: 8 cc tetrabutylammonium chloride: 0.02 mmol sodium methylate: 8 mmol
After heating for 22 hours at 60.degree. C., methyl N-methyl-10.alpha.-methoxylumilysergate (0.72 mmol) was formed in a 72% yield.
Claims
  • 1. A process for preparing an N-methyl compound of ergoline of formula: ##STR5## in which R.sub.1 denotes a carboxy or alkoxycarbonyl group in which the alkyl portion contains 1 to 4 carbon atoms, R.sub.2 denotes a hydrogen atom or a methoxy group and R.sub.3 denotes a hydrogen atom or R.sub.2 and R.sub.3 together form a direct bond, or in which R.sub.1 denotes a hydroxymethyl group, R.sub.2 denotes a hydrogen atom or a methoxy group and R.sub.3 denotes a hydrogen atom, which comprises methylating an ergoline compound of formula: ##STR6## in which R.sub.1, R.sub.2 and R.sub.3 are defined as above, with methyl carbonate in the presence of an alkali metal alcoholate, in an apolar aprotic solvent in the presence of a phase transfer catalyst.
  • 2. A process according to claim 1 which is carried out in the presence of a sequestering agent.
  • 3. A process according to claim 1, wherein the solvent is an ether, ester, nitrile or aromatic hydrocarbon.
  • 4. A process according to claim 1, wherein the solvent is methyl carbonate.
  • 5. A process according to claim 1, wherein the phase transfer catalyst is a quaternary ammonium salt.
  • 6. A process according to claim 5, wherein the phase transfer catalyst is tetrabutylammonium chloride.
  • 7. A process according to claim 2, wherein the sequestering agent is a crown ether or a compound of formula:
  • N(CH.sub.2 CH.sub.2 (OCH.sub.2 CH.sub.2).sub.n OCH.sub.3).sub.3
  • wherein n is 1, 2 or 3.
  • 8. A process according to claim 1, wherein the reaction temperature is from 0.degree. to 100.degree. C.
Priority Claims (1)
Number Date Country Kind
85 10620 Jul 1985 FRX
US Referenced Citations (5)
Number Name Date Kind
3218323 Hofmann et al. Nov 1965
3228943 Bernardi et al. Jan 1966
3272823 Arcamone et al. Sep 1966
3879554 Temperilli Apr 1975
4232157 Enrico Nov 1980
Foreign Referenced Citations (4)
Number Date Country
631701 Nov 1961 CAX
100569 Dec 1964 DKX
0000533 Jul 1979 EPX
2116548 Sep 1983 GBX
Non-Patent Literature Citations (5)
Entry
Romano et al., CA 94-65300h, Aromatic Alkyl Amines.
Merger et al., CA 88-37405d, Aralkylarylamines and Alkylarylamines.
Societa Farmaceutici Italia, CA 61-3160, New Derivatives of Lumilysergol.
Maffrand et al., CA 96-199659g, Indolizeno 28, 7-63, Indole Derivatives, Intermediates, and Their Therapeutic Use.
Reinecke et al, J. Org. Chem., vol 37, No. 20, 1972, The Effect of Solvent and Cation on the Reaction of Organometallic Derivatives of Indole with Methyl Iodide.